Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Science Advances|June 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRsGiancarlo Croce, Rachid Lani, Delphine Tardivon, et al.The Journal of Clinical Endocrinology and Metabolism|March 30, 2012
The endemic paraganglioma syndrome type 1: origin, spread, and clinical expressionFrancesca Schiavi, Serena Demattè, Maria Enrica Cecchini, et al.Nature Communications|September 29, 2025
Neuron-reactive KIR+CD8+ T cells display an encephalitogenic transcriptional program in autoimmune encephalitisSylvain Perriot, Samuel Jones, Raphaël Genolet, et al.Nature Biotechnology|November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumorsMarion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.Nature Communications|March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancerSara Bobisse, Raphael Genolet, Annalisa Roberti, et al.Cancer Immunology Research|October 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer ImmunotherapyMyriam Ben Khelil, Maxime Fredon, Nawfel Adib, et al.Nature Biotechnology|May 7, 2024
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.Nature Cancer|September 22, 2023
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancerSara Bobisse, Valentina Bianchi, Janos L Tanyi, et al.Nature Biotechnology|October 11, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapyFlorian Huber, Marion Arnaud, Brian J Stevenson, et al.Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.Pageof 5